Results 51 to 60 of about 748,108 (220)
Molecular Oncology, EarlyView.In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen +13 more
wiley +1 more source
Journal of Health Science and Medical Research (JHSMR), 2016 Objective: The purpose of this study was to organize the data of blood donors’ antigens into a database for providing compatible blood for patients, especially those who are activated to produce antibodies.
Darinnat Buathong, Sarunya Hassarin
doaj
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Molecular Oncology, EarlyView.Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini +11 more
wiley +1 more source
ABO histo-blood group and risk of respiratory atopy in children: a review of published evidence
Pediatric Health, Medicine and Therapeutics, 2018 Samuel N Uwaezuoke,1 Joy N Eze,1 Adaeze C Ayuk,1 Ikenna K Ndu2 1Department of Paediatrics, University of Nigeria Teaching Hospital (UNTH), Ituku-Ozalla Enugu, Nigeria; 2Department of Paediatrics, Enugu State University Teaching Hospital, Enugu, Nigeria ...
Uwaezuoke SN, Eze JN, Ayuk AC, Ndu IK
doaj
Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors
Molecular Oncology, EarlyView.Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi +6 more
wiley +1 more source
Statistical Analysis of Behavioral Intention Towards Private Umbilical Cord Blood Banking [PDF]
arXiv, 2020 In this paper, we propose a conceptual framework to identify the key dimensions affecting behavioral intention to bank umbilical cord blood in Iran. We examine the impact of awareness, reference group, usability, disease history, and price on perceived risk and behavioral intention to use umbilical cord blood banking service.
arxiv
Pediatric patient with Bombay blood group: A rare case report
Saudi Journal of Anaesthesia, 2015 Bombay blood group is a rare blood group in which there is the absence of H antigen and presence of anti-H antibodies. At the time of blood grouping, this blood group mimics O blood group due to the absence of H antigen, but it shows incompatibility with
Sudeshna Bhar (Kundu) +3 more
doaj +1 more source
Molecular Oncology, EarlyView.This study simultaneously investigated circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients. The elevated expression of JUNB and CXCR4 in CTCs was a poor prognostic factor for SCLC patients, whereas exosomal overexpression of these biomarkers revealed a high discrimination ability of patients from healthy individuals,
Dimitrios Papakonstantinou +13 more
wiley +1 more source
ANNCRIPS: Artificial Neural Networks for Cancer Research In Prediction & Survival [PDF]
arXiv, 2023 Prostate cancer is a prevalent malignancy among men aged 50 and older. Current diagnostic methods primarily rely on blood tests, PSA:Prostate-Specific Antigen levels, and Digital Rectal Examinations (DRE). However, these methods suffer from a significant rate of false positive results.
arxiv
Detection of Du Antigen in Rh Negative Blood Group Individuals
RADS Journal of Biological Research & Applied Science, 2013 Du is the weak expression of D antigen. The cells which are not immediately agglutinated by Anti-D sera cannot be easily classified as D negative because some of these agglutinate after addition of antiglobulin sera. This weak reactivity is termed as Du.
Naheed Afshan1
doaj